Project Grant R37CA283353
Award Date
8/6/24
Completion Date
7/31/29
Dollars Obligated
$664K
Federal Agency
National Cancer Institute
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
This $290,052 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and evaluation of a mobile-optimized intervention called PERCS-YA (Personalized Cancer Support for Young Adults) to reduce worry and distress among young adult cancer survivors. The award will fund stakeholder-engaged refinement of the PERCS-YA intervention, followed by a Phase II efficacy trial utilizing both a...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $161,432 to The University of Texas MD Anderson Cancer Center to develop and evaluate a virtual, group-based expressive writing intervention for adolescent and young adult cancer survivors (AYACSS). The overarching goal is to enhance the quality of life and reduce stress among this population, who face multiple psychosocial disparities. The award will fund a 2-year research plan with the...
This Project Grant award for $166,984 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports efforts to increase enrollment of adolescent and young adult (AYA) cancer patients on clinical trials at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins University. The project will develop and implement an "AYA: ALERT, Young Adult Navigation, Alliance" system to identify eligible AYA patients, provide them with timely information about...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $185,693 to the Research Institute at Nationwide Children's Hospital to fund a digital health parent coaching intervention to improve neurodevelopmental outcomes for young childhood cancer survivors in underserved communities. The 5-year project aims to develop and evaluate a technology-enabled program that supports parents of young childhood cancer survivors, who are at high risk of...
The National Cancer Institute (NCI) awarded a $794,530 Project Grant under the CFDA 93.394 Cancer Detection and Diagnosis Research program to the Sloan-Kettering Institute for Cancer Research. The 5-year grant, starting on September 1, 2024, will fund a randomized controlled trial to evaluate the efficacy of time-restricted eating in reducing weight and improving cardiometabolic risk factors among 300 radiation-exposed survivors of childhood cancer with overweight/obesity. The study will...
The National Cancer Institute (NCI) awarded a $1,909,966 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Xanthoshealth, Inc. to develop and evaluate ConnectedNest, a digital platform that connects individuals with cancer to social and community services. The 2-year project aims to enhance the technical infrastructure of the ConnectedNest platform, extend its integration capabilities, and conduct a randomized clinical trial involving 300 adults in oncology...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $222,749 to Rutgers, The State University of New Jersey to develop and pilot test a single-session digital intervention to support adolescent siblings of children with cancer. The key objectives are to: 1) adapt an existing single-session intervention to address the needs of this population, 2) evaluate the feasibility, acceptability, and preliminary outcomes of the intervention, and 3)...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $361,807 to the University of Chicago to tailor and pilot test a technology-assisted cognitive behavioral therapy (TCBT) program for adolescents and young adults (AYAs) with hematological malignancies. The key objectives are to: 1) Collaborate with an advisory panel of AYA cancer survivors and stakeholders to refine the existing TCBT program "MYTH" for the specific needs of...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $656,046 to the University of Colorado to conduct a randomized trial of a novel behavioral intervention called EASE. The goal is to address fear of progression and cancer-related trauma symptoms among adults with advanced cancer. The 5-year study, which began on August 1, 2025, will evaluate the EASE intervention delivered via telehealth compared to usual care,...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) awarded a $388,712 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Dana-Farber Cancer Institute (DFCI) in Boston, MA. The "Young Empowered Scientists for Continued Research Engagement (YES for CURE)" program aims to increase participation and retention of underrepresented minority students in cancer-related STEM fields. The multi-year program will provide high school...